Microbicide Trials Network

MTN-001

A Phase II trial that looked at differences in how the ARV tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel, as well as women’s preferences or ability to adhere to daily regimens of each approach.

 

See

Tenofovir Gel Wins Out in Drug Absorption Study, but HIV Prevention Trials Tell a Different Story

30-January-2013

     

Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue

28-February-2011

  

HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study

9-July-2008

     

MTN-001 Q&A

30-January-2013

 

See Also

MTN-001 Study Protocol